| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |